Weizmann Institute Scientists Find that Targeting a Chronic Pain Gateway Could Bring Relief

A study led by Prof. Mike Fainzilber identifies a potential new approach to treating chronic pain: targeting an importin molecule that moves pain messages into nerve cell nuclei. The team can now “conduct screens for new and better drug molecules that can precisely target this chain of events in the sensory neurons.”

Other treatments can reduce need for addictive pain medication

Hardly a day goes by without the public being warned about the dangers of opioids. But still, according to the National Institute on Drug Abuse, more than 130 people die every day of opioid overdose and the problem is getting worse. A Houston Methodist pain specialist says new advancements in pain management are giving patients options.